Conclusions
In patients with severe aortic valve stenosis presenting acutely, the haemodynamic instability and resistance to optimized drug therapy may require an urgent intervention. BAV remains a viable treatment option. Outcomes in patients bridged to AVR/TAVI are better than in patients treated with BAV alone. Owing to the high mortality of patients in this cohort without destination therapy, delays to progression to TAVR or AVR should be avoided. Urgent or emergency TAVR may be associated with improved survival outcomes when compared with BAV as a bridge to subsequent TAVR or SAVR. Urgent TAVR may be associated with increased peri-procedural risk but outcomes are acceptable and this approach is a viable alternative for this patient population.